The 16th SFBMEC congress was held last week in Reims: Elodie and Zied attended the meeting to be aware of the last trends in extracellular matrix (ECM) research and industry and medical applications. And they were not disappointed! After a first touching lecture in memoriam of the late Ladislas Robert Read more…
Our study director Elodie really enjoyed Vitafoods last week in Geneva, and the welcome she had on the different booths she visited along the three days! The show was very impressive, with a wide variety of exhibitors (more than 1.000 companies) and more than 20.000 visitors! Elodie spent much time Read more…
Last week HCS Pharma team enjoyed Forum Labo Paris! We enjoyed it twofold because : we won our booth on the Lab’StartUp Village, in the heart of the fair. It gave us the opportunity to present our BIOMIMESYS® products! we won a price for our amazing photo of liver cells… Read more…
Next week HCS Pharma will be present both at Forum Labo Paris (26th-28th March ) and at SCMC congress in Lille (28-29th March)! In Forum Labo we will have our own stand in the Lab’StartUp Village (stand G11), thanks to the organizers for selecting BIOMIMESYS® Brain for the fair! We Read more…
BIOMIMESYS® Oncology is mostly composed of hyaluronic acid (HA), biofunctionnalized with undenaturated collagen I. HA, by interacting with its binding proteins (CD44, RHAMM, ICAM-1), is an active participant in inflammatory, angiogenic, fibrotic and cancer-promoting processes (Figure 1). We are currently looking at the effect of different elastic moduli of BIOMIMESYS® Read more…
HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to the committee for evaluating our application to this prize, and for selecting our new product Read more…
Extracellular matrix (ECM) is known to have an influence on physiological processes and on tumour progression: ECM properties (composition, stiffness) modulate cell proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT). For example, EMT is inhibited by laminin-rich environment whereas it is promoted in fibronectin-rich ECM (Chen et al 2013. Differentiation 86, Read more…
Large number of visitors came to Cosmet’agora last week to discover the last innovations in cosmetic formulation. It was a great opportunity to discuss with leader companies developing active ingredients and to feel emerging trends in the cosmetic market: microbiota balance preservation and chronobiology in particular. Our fully automatic wound Read more…
Our study directors Elodie and Pierre-Jean enjoyed the last edition of Health Ingredients Europe, which took place in Frankfurt (Germany) from the 27th to the 28th of November 2018. For their first time in HIE, they appreciated the organization and size of the salon, as well as the networking opportunities Read more…
HCS Pharma team enjoyed attending BioFit 2018 and hosted events in Lille last week! Our business developer Nathalie had many fruitful BtoB meetings along the convention, and our study director Elodie could meet lots of people interested in our imaging technology and BIOMIMESYS products while on HCS pharma booth (D4/2) Read more…
Our study directors Elodie and Pierre-Jean will attend “HI Europe” in Frankfurt next week. We cordially invite you to discuss with them, they will be happy to present our imaging services related to nutraceutical testing! We are equipped to test from one to thousands of ingredients on any of our state-of-the-art Read more…
In this article, researchers from Sorbonne University (Paris, France) proposed an explanation for the patterns followed by breast cancer cells when seeded in BIOMIMESYS, i.e. spherical aggregates. Usually, mathematical models dealing with the formation of patterns by cells in the extracellular matrix do not take into account the chemical environmental Read more…
Last week we attended ELRIG UK Drug Discovery meeting in ExCeL London, and it was a great pleasure for us to present our poster about neurotoxicity testing using HCS there. Many interesting posters were displayed in the vendor area (see below), allowing exciting scientific discussions between the sessions! We enjoyed Read more…
Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Elodie there, she will answer to your questions about our results, and/or our different services! Read more…
It is a great pleasure for us to welcome a new member in our scientific advisory board, Dr Samuel Meignan! He will for sure help us to develop relevant models related to oncology therapeutic area. Dr. Samuel Meignan is a senior researcher at the Inserm U908 laboratory ‘Cell Plasticity and Read more…
Last week we had the pleasure to attend the first SLAS Europe (Society for Laboratory Automation and Screening) meeting, which took place in the great Brussels Square meeting centre (Belgium) between the 27th and the 29th of June. Bringing together more than 1,000 academic and industry scientists from all around Read more…
HCS pharma has organized its second scientific advisory board! We were pleased to gather around the table (physically or via a Webex visioconference for those who could not make the trip) David Devos, Roméo Cecchelli, George Haase, Karim Si Tayed… and a new board member: Dominique Collard! Dominique is known Read more…
Since the liver is responsible for the selective uptake, metabolism and excretion of xenobiotics, this organ is highly predisposed to drug-induced toxicity: this essential function is the primary reason for the failure of pharmaceuticals during drug development (Ref 1.). Cholestatic and hepatocellular injuries are two of the most severe manifestations of Read more…
We had the pleasure to attend ELRIG Fr meeting in Bischoffsheim (near Strasbourg) on the 23-24th of May. There we enjoyed meeting our partners Molecular Devices and Integra biosciences, and seeing great presentations about the last trends in automation. Our collaborator Karim Si-Tayeb presented his amazing results regarding the differentiation Read more…
The first EUROoC meeting, dealing with organ-on-chip research and organized by the Chemical and Biological Microsystems Society (CBMS), will take place on the 24th-25th of May 2018 in Stuttgart (Germany). Interestingly, this new workshop will address the engineering challenges related to the design, fabrication and implementation of organ-on-chips (OOC) and microphysiological systems. Among other Read more…
Next week (the 23th and the 24th of May), we will be in Strasbourg to participate to ELRIGfr event, where we will present two posters. The first poster is about BIOMIMESYS® hydroscaffold for 3D cell culture and the compatibility with automation; the plates can be seeded, treated easily using the VIAFLO 96/384. Read more…
Thanks a lot to Integra biosciences‘ and Molecular Devices‘ teams to have welcomed us on their respective booths at Forum Labo Lyon! It was a great pleasure to take part in this event by their side, as a proof of our fruitful – and hopefully long lasting – collaboration ! Read more…
The annual congress of the SCMC (French Brain and Cerebrovascular Diseases Society) took place in Paris last week. The meeting began with a mini-symposium entitled “Nanoparticles and the brain”, during which the therapeutic potential of nanomedicine was addressed: three invited speakers discussed the use of nanoparticules to treat cancers (by Read more…